Видео ютуба по тегу Egfr Mutant Nsclc

Current treatment recommendations and future directions for EGFR-mutant NSCLC
Current treatment recommendations and future directions for EGFR-mutant NSCLC
Emerging treatment strategies in EGFR-mutant NSCLC: osimertinib combinations and beyond
Emerging treatment strategies in EGFR-mutant NSCLC: osimertinib combinations and beyond
Consolidation therapy for unresectable stage III EGFR-mutant NSCLC
Consolidation therapy for unresectable stage III EGFR-mutant NSCLC
TKI-resistant EGFR-mutant NSCLC
TKI-resistant EGFR-mutant NSCLC
Frontline Afatinib in EGFR-Mutant NSCLC
Frontline Afatinib in EGFR-Mutant NSCLC
Shifting Prognoses of Patients With EGFR-Mutant NSCLC
Shifting Prognoses of Patients With EGFR-Mutant NSCLC
Dr. Piotrowska on Treatment for EGFR-Mutant NSCLC
Dr. Piotrowska on Treatment for EGFR-Mutant NSCLC
EGFR-Mutant NSCLC: Selecting Patients for Osimertinib
EGFR-Mutant NSCLC: Selecting Patients for Osimertinib
Understanding EGFR-Mutant NSCLC Subsets
Understanding EGFR-Mutant NSCLC Subsets
Amivantamab and lazertinib in treatment-naïve EGFR-mutant NSCLC
Amivantamab and lazertinib in treatment-naïve EGFR-mutant NSCLC
Dr. Bazhenova on Sequencing Beyond Progression in EGFR-Mutant NSCLC
Dr. Bazhenova on Sequencing Beyond Progression in EGFR-Mutant NSCLC
A Case of EGFR-Mutant NSCLC
A Case of EGFR-Mutant NSCLC
EGFR-Mutant NSCLC: Optimizing Therapy Selection
EGFR-Mutant NSCLC: Optimizing Therapy Selection
Dr. Konduri on Treatment Options for Patients With EGFR-Mutant NSCLC
Dr. Konduri on Treatment Options for Patients With EGFR-Mutant NSCLC
Atezolizumab with erlotinib in combination treatment for EGFR mutant NSCLC
Atezolizumab with erlotinib in combination treatment for EGFR mutant NSCLC
Dr. Low on Osimertinib Versus Dacomitinib in EGFR-Mutant NSCLC
Dr. Low on Osimertinib Versus Dacomitinib in EGFR-Mutant NSCLC
Sequencing of Therapies in EGFR-Mutant NSCLC
Sequencing of Therapies in EGFR-Mutant NSCLC
15 Years of Advances in EGFR Mutant Lung Cancer
15 Years of Advances in EGFR Mutant Lung Cancer
Molecular testing in EGFR mutant driven NSCLC
Molecular testing in EGFR mutant driven NSCLC